12 Health Care Stocks Moving In Friday's After-Market Session

Loading...
Loading...

Gainers

  • HOOKIPA Pharma HOOK stock moved upwards by 8.5% to $2.69 during Friday's after-market session. HOOKIPA Pharma's trading volume hit 1.4 million shares by close, accounting for 40.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $80.5 million.
  • Alaunos Therapeutics TCRT stock moved upwards by 7.74% to $0.9. The market value of their outstanding shares is at $194.5 million.
  • Exscientia EXAI shares increased by 6.32% to $19.0. The company's market cap stands at $2.2 billion.
  • Mustang Bio MBIO shares increased by 6.29% to $0.94. The company's market cap stands at $87.8 million.
  • Clovis Oncology CLVS stock rose 5.26% to $1.8. The market value of their outstanding shares is at $233.9 million.
  • Evoke Pharma EVOK shares increased by 4.61% to $0.68. The company's market cap stands at $22.2 million.

Losers

  • Caladrius Biosciences CLBS stock decreased by 8.9% to $0.7 during Friday's after-market session. The market value of their outstanding shares is at $41.8 million.
  • Modular Medical MODD stock declined by 8.31% to $2.76. The company's market cap stands at $17.6 million.
  • Regencell Bioscience RGC stock declined by 7.9% to $35.0. The company's market cap stands at $453.8 million.
  • Aptorum Group APM shares declined by 3.98% to $1.69. The company's market cap stands at $60.2 million.
  • Rubius Therapeutics RUBY shares decreased by 3.5% to $4.97. The company's market cap stands at $446.6 million.
  • Gelesis Holdings GLS shares decreased by 3.16% to $3.07. The company's market cap stands at $221.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...